Showing results (2961-2970 of 27,712) with videos related to

Sort By:
Pageof 2,772
Vaccine|December 1, 1983
Computerization of foot and mouth disease virus strain relationship dataG West, M M Rweyemamu, M Head, et al.
Vaccine|September 1, 1984
Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strainR J Klein, L A Kaley, A E Friedman-Kien
Vaccine|October 1, 1994
Effect of a lipopeptidic formulation on macrophage activation and peptide presentation to T cellsF Rouaix, H Gras-Masse, C Mazingue, et al.
Vaccine|October 1, 1994
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbuminS Tamura, Y Shoji, K Hasiguchi, et al.
Vaccine|March 14, 2008
Augmentation of SIV DNA vaccine-induced cellular immunity by targeting the 4-1BB costimulatory moleculeSandra A Calarota, David A Hokey, Anlan Dai, et al.
Vaccine|March 14, 2008
Kinetics of asthma- and allergy-associated immune response gene expression in peripheral blood mononuclear cells from vaccinated infants after in vitro re-stimulation with vaccine antigenAnne I Lahdenperä, Lennart J Nilsson, Karin Regnström
Vaccine|March 14, 2008
Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccineSamadhan J Jadhao, Jenna Achenbach, David E Swayne, et al.
Vaccine|March 18, 2008
Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattleV L Fowler, D J Paton, E Rieder, et al.
Vaccine|March 4, 2008
Influenza vaccination acceptance among health-care workers: a nationwide surveyHelen C Maltezou, Antonios Maragos, Panos Katerelos, et al.
Vaccine|January 1, 2008
Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccinesCosette M Wheeler, Oliver M Bautista, Joanne E Tomassini, et al.
Pageof 2,772